Carasent: Comments on Vitruvian Partners and the private placement

Yesterday, Vitruvian Partners invested NOK 420m in a private placement, making the private equity firm Carasent’s largest shareholder. We give our view on the news.

MS

Mark Siöstedt

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.